148 related articles for article (PubMed ID: 11920957)
1. Anoikis is regulated by BCL-2-independent pathways in human prostate carcinoma cells.
Bondar VM; McConkey DJ
Prostate; 2002 Apr; 51(1):42-9. PubMed ID: 11920957
[TBL] [Abstract][Full Text] [Related]
2. Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals.
Giannoni E; Fiaschi T; Ramponi G; Chiarugi P
Oncogene; 2009 May; 28(20):2074-86. PubMed ID: 19377510
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line.
McConkey DJ; Greene G; Pettaway CA
Cancer Res; 1996 Dec; 56(24):5594-9. PubMed ID: 8971161
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.
Raffo AJ; Perlman H; Chen MW; Day ML; Streitman JS; Buttyan R
Cancer Res; 1995 Oct; 55(19):4438-45. PubMed ID: 7671257
[TBL] [Abstract][Full Text] [Related]
5. Src activation regulates anoikis in human colon tumor cell lines.
Windham TC; Parikh NU; Siwak DR; Summy JM; McConkey DJ; Kraker AJ; Gallick GE
Oncogene; 2002 Nov; 21(51):7797-807. PubMed ID: 12420216
[TBL] [Abstract][Full Text] [Related]
6. microRNA-205 and microRNA-338-3p Reduces Cell Apoptosis in Prostate Carcinoma Tissue and LNCaP Prostate Carcinoma Cells by Directly Targeting the B-Cell Lymphoma 2 (Bcl-2) Gene.
Zhang X; Pan Y; Fu H; Zhang J
Med Sci Monit; 2019 Feb; 25():1122-1132. PubMed ID: 30741252
[TBL] [Abstract][Full Text] [Related]
7. [Screening of phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) by cDNA microarray and influence of overexpression of PAG1 on biologic behavior of human metastatic prostatic cancer cell line in vitro].
Yu WJ; Wang YW; Xie ZG; You JF; Wang JL; Cui XL; Pei F; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):88-94. PubMed ID: 20388373
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells.
Li X; Marani M; Mannucci R; Kinsey B; Andriani F; Nicoletti I; Denner L; Marcelli M
Cancer Res; 2001 Feb; 61(4):1699-706. PubMed ID: 11245486
[TBL] [Abstract][Full Text] [Related]
9. Induction of anoikis and suppression of human ovarian tumor growth in vivo by down-regulation of Bcl-X(L).
Frankel A; Rosen K; Filmus J; Kerbel RS
Cancer Res; 2001 Jun; 61(12):4837-41. PubMed ID: 11406560
[TBL] [Abstract][Full Text] [Related]
10. miR-143 Induces the Apoptosis of Prostate Cancer LNCap Cells by Suppressing Bcl-2 Expression.
Ma Z; Luo Y; Qiu M
Med Sci Monit; 2017 Jan; 23():359-365. PubMed ID: 28109198
[TBL] [Abstract][Full Text] [Related]
11. Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells.
Park SI; McCauley LK
Endocr Relat Cancer; 2012 Jun; 19(3):243-54. PubMed ID: 22291434
[TBL] [Abstract][Full Text] [Related]
12. Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.
Keledjian K; Kyprianou N
J Urol; 2003 Mar; 169(3):1150-6. PubMed ID: 12576871
[TBL] [Abstract][Full Text] [Related]
13. Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation.
Mawji IA; Simpson CD; Hurren R; Gronda M; Williams MA; Filmus J; Jonkman J; Da Costa RS; Wilson BC; Thomas MP; Reed JC; Glinsky GV; Schimmer AD
J Natl Cancer Inst; 2007 May; 99(10):811-22. PubMed ID: 17505076
[TBL] [Abstract][Full Text] [Related]
14. BCL2 antisense transcripts decrease intracellular Bcl2 expression and sensitize LNCaP prostate cancer cells to apoptosis-inducing agents.
Shi XB; Gumerlock PH; Muenzer JT; deVere White RW
Cancer Biother Radiopharm; 2001 Oct; 16(5):421-9. PubMed ID: 11776759
[TBL] [Abstract][Full Text] [Related]
15. Translationally regulated C/EBP beta isoform expression upregulates metastatic genes in hormone-independent prostate cancer cells.
Kim MH; Fields J
Prostate; 2008 Sep; 68(12):1362-71. PubMed ID: 18512730
[TBL] [Abstract][Full Text] [Related]
16. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
[TBL] [Abstract][Full Text] [Related]
17. Antisense Bcl-2 sensitizes prostate cancer cells to radiation.
Mu Z; Hachem P; Pollack A
Prostate; 2005 Dec; 65(4):331-40. PubMed ID: 16015611
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of heat-shock protein (HSP)70 expression induced cell growth inhibition and apoptosis in human androgen-independent prostate cancer cell line PC-3m.
Zhao ZG; Ma QZ; Xu CX
Asian J Androl; 2004 Dec; 6(4):319-24. PubMed ID: 15546023
[TBL] [Abstract][Full Text] [Related]
20. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M
Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
